By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Zsuzsanna Izsvák at the Max Delbrück Center for Molecular Medicine has been awarded a five-year, €1.94 million ($2.55 million) grant to study the role of transposons in cancer and other diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The New York Times editorial board weighs in on scientific research misconduct.